Nigella sativa seed constituents and anxiety relief in experimental models

Journal of Herbs, Spices and Medicinal Plants

Volumn 12, Issue 1-2, 2006, Pages 153-164

  Raza, M ^a   El Hadiyah, T M ^b   Al Shabanah, O A ^b  

^a QASSIM UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

pinene; Anxiolysis; Benzodiazepine receptors; p cymene; Thymoquinone

Indexed keywords

BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; ESSENTIAL OIL; FLUMAZENIL; LORAZEPAM; NIGELLA SATIVA EXTRACT; PARA CYMENE; PINENE; THYMOQUINONE;

BEHAVIOR; ESSENTIAL OIL; EXPERIMENTAL STUDY; MEDICINAL PLANT; MODEL TEST; SEED;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BLACK CUMIN; CONFLICT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; EXPERIMENTAL TEST; MALE; MAZE TEST; MOUSE; NONHUMAN; PLANT SEED; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

ANIMALIA; NIGELLA SATIVA;

EID: 33845934975     PISSN: 10496475     EISSN: 15403580     Source Type: Journal    
DOI: 10.1300/J044v12n01_14     Document Type: Article

References (40)

1. Abdel-Fattah, A.M., K. Matsumoto, and H. Watanabe. 2000. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur. J. Pharmacol. 14:400, 89-97.
2. AbouBasha, L.I., M.S. Rashed, and Y. Aboua-Enein. 1995. TLC assay of thymoquinone in black seed oil (Nigella sativa) and identification of dithymoquinone and thymol. J. Liq. Chromatogr. 18:105-115.
3. Aboutabl, E.A., A.A. El-Azzouny, and F.J. Hammerschmidt. 1986. Aroma volatile of Nigella sativa seeds. Prog. Essent. Oil Res. Proc. Int. Symp. Essent. Oils Vol. 16. pp. 49-55.
4. Akhtar, A.M., K.D. Ahmad, S.N. Gilani, and A. Nazir. 1996. Antiulcer effects of aqueous extracts of Nigella sativa and Pongamia pinnata in rats. Fitoterapia. 57:195-1999.
5. Al-Awadi, F.M., M.A. Mukhtar, K.A. Gumma. 1985. On the mechanism of the hypoglycemic effect of a plant extract. Diabetologia. 28(7):432-434.
6. Al-Jassir, M.S. 1992. Chemical composition and microflora of black cumin (Nigella sativa) seeds growing in Saudi Arabia. Food Chemistry. 45:239-242.
7. Al-Naggar, T.B., M.P. Gomez-Serranillos, M.E. Carretero, and A.M. Villar. 2003. Neuropharmacological activity of Nigella sativa L. extracts. J Ethnopharmacol. 88:63-68.
8. Babayan, V.K., D. Kootungal, and G.A. Halaby. 1978. Proximate analysis, fatty acid and amino acid composition of Nigella sativa seeds. J. Food Sci. 43:1314-1315.
9. Budavari, S. ed 1996. Merck index, 12th Ed. Merck and Co., Inc., Whitehouse Station, NJ.
10. Canonica, L., G. Jomoni, C. Scolastico, and A. Bonati. 1963. The pharmacologically active principle in Nigella sativa. Gazz. Chem. Ital. 93:1404-1407.
11. Choi, D.W., D.H. Farb, and G.D. Fischbach. 1981. Chlodiazepoxide selectively potentiates GABA conductance of spinal cord and sensory neurons in cell culture. J Neurophysiol. 45:621-631.
12. Costa, E. and A. Guidotti. 1979. Molecular mechanisms in the receptor action of benzodiazepines. Ann Rev Pharmacol Toxicol. 19:531-545.
13. De-Anglis, L. 1992. The anxiogenic-like effects of pentylenetetrazole in mice treated chronically with carbamazepine or valproate. Methods Find. Exp. Clin. Pharmacol. 14:767-771.
14. De-Anglis, L. 1995. Effects of valproate and lorazepam on experimental anxiety: Tolerence, withdrawal, and role of clonidine. Pharmacol. Biochem. Behav. 52:329-333.
15. El-Alfy, T.S., H.E. El-Fatatry, and M.A. Toama. 1975. High performance liquid chromatographic analysis of the pharmacologically active quinines and related compounds in the oil of the black seeds (Nigella sativa L.). Pharmazie. 30:109.
16. El-Dakhakhny, M. 1963. Studies on the chemical constitution of Egyptian Nigella sativa L. Seeds. Pharmazie. 30:109-111.
17. El-Fatary, H.M. 1975. Isolation and structure assignment of an antimicrobial principle from the volatile oil of Nigella sativa L. seeds. Pharmazie. 30(2):109-111.
18. El-Hadiyah, T.M., M. Raza, O.Y. Mohammed, and A.A. Abdallah. 2003. Evaluation of Nigella sativa constituents for their in vivo toxicity in mice. Natural Product Sciences. 9(1):22-27.
19. Field, M.J., R.J. Oles, and L. Singh. 2001. Prgabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity. Br Journ. Pharmacol. 132:1-4.
20. Ghelardini, C., N. Galeotti, F. Gualtieri, C. Bellucci, D. Manetti, A. Giotti, P. Malmberg-Aiello, A. Galli, and A. Bartolini. 1997. Antinociceptive profile of 3-α-tropanyl-(2-Cl)-acid phenoxybutyrate (SM-21): A novel analgesic with a presynaptic cholinergic mechanism of action. J. Pharmacol. Exp. Therap. 282: 430-439.
21. Ghosheh, O.A., A.A. Houdi, and P.A. Crooks. 1999. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J Pharm Biomed Anal. 19(5):757-762.
22. Griebel, G., G. Perrault, and D.J. Sanger. 1998. Characterization of the behavioural profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology (Berl). 138:55-66.
23. Hag, A., M. Al Tufail, P.I. Lobo, K.S.A. Khabar, K.V. Sheth, and S.T. Al-Sedairy. 1995. Polymorphnuclear leukocyte phagocytic activity. Immunopharmacology. 30:147-155.
24. Hashim, F.M. and M.A. El-Kiey. 1962. Nigella sativa seeds of Egypt. J. Pharm. Sci. UAR. 3:121-133.
25. Hiramatsu, M. and K. Inoue. 1999. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice. Br. J Pharmacol. 127:655-660.
26. Houghton, P.J., R. Zaka, P.D. Hera, and J.R.S. Hoult. 1995. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Medica. 61:33-36.
27. Hunkler, W., H. Mohler, L. Pieri, P. Polc, and W. Haefely. 1981. Selective antagonism of benzodiazepines. Nature. 290:514-516.
28. Khanna, T, F.A. Zaidi, and P.C. Dandiyn. 1993. CNS and analgesic studies onNigella sativa. Fitoterapia. 64:407-410.
29. Macdonald, R.L. and M.J. McLean. 1986. Anticonvulsant drugs: Mechanism of action. Adv Neurol. 44:713-735.
30. Martin, I.L. 1987. The benzodiazepines and their receptors: 25 years of progress. Neuropharmacology. 26:957-970.
31. O'Sullivan, G.F. and D.N. Wade. 1987. Flumazenil in the management of acute drug overdose with benzodiazepine and other agents. Clin. Pharmacol. Ther. 42:254-259.
32. Ochs, M.W., M.R. Tucker, T.G. Owsley, and J.A. Anderson. 1990. The effectiveness of flumazenil in reversing the sedation and amnesia produced by intravenous midazolam. J Oral Maxillofac Surg. 48:240-245.
33. Petersen, E.N. and J.B. Lassen. 1981. A water-lick conflict paradigm using drug experienced rats. Psychopharmacology. 75:236-239.
34. Phillis, J.W. and M.H. O'Regan. 1988. The role of adenosine in the central action of benzodiazepines. Prog. Neuropsuchopharmacol. Biol. Psychiatry. 12:389-404.
35. Polc, P. 1988. Electrophysiology of benzodiazepine receptor ligands: Multiple mechanisms and site of action. Prog. Neurobiol. 31:349-423.
36. Salama, R.B. 1973. Sterols in the seed oil of Nigella sativa. Planta Med. 24:375-377.
37. Sayed, M.D. 1980. Traditional medicine in health care. J. Ethnopharmacol. 2:19-22.
38. Study, R.E. and J.L. Baker J.L. 1982. Cellular mechanism of benzodiazepine action. J. Amer Med Assoc. 247:2147-2151.
39. Twyman, R.E., C.J. Rogers, and R.L. Macdonald. 1989). Differential regulation of G-aminobutyric acid receptor channels by diazepam and Phenobarbital. Ann Neurol. 25:213-220.
40. Vogel, J.R., B. Beer, and D.E. Cldy. 1971. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia. 21:1-7.